跳至主要内容
临床试验/CTRI/2026/03/106138
CTRI/2026/03/106138尚未招募Phase 3 4

A CONTROLLED CLINICAL STUDY TO EVALUATE THE EFFECT OF RALA SARSHAPA DHOOPANA IN THE MANAGEMENT OF RAKTARSH W.S.R. TO BLEEDING HAEMORRHOIDS.

Dr Swarnima Nilesh Kucheriya1 个研究点 分布在 1 个国家目标入组 66 人开始时间: 2026年3月31日最近更新:

试验速览

阶段
Phase 3 4
状态
尚未招募
发起方
入组人数
66
试验地点
1

研究概览

简要总结

The Present Study is a PG Thesis Topic

By PG Scholar - DR SWARNIMA NILESH KUCHERIYA and Guide Name - DR VARSHA TANGADE

Title - A CONTROLLED CLINICAL STUDY TO EVALUATE THE EFFECT OF

RALA SARSHAPA DHOOPANA IN THE MANAGEMENT OF RAKTARSH W.S.R. TO

BLEEDING HAEMORRHOIDS.

According to inclusion and exclusion criteria

Group A 33 patients and Group B 33 patients will be selected

Group A ( intervention ) will be given Rala Churna sarshapa taila dhoopana locally 10 minutes daily for 7 days

Group B ( control/ comparative ) will be given -calcium dobesilate with hydrocortisone ointment local application Once a day for 7 days

Total Duration of study is 1 year 6 months.

研究设计

研究类型
Interventional
分配方式
Randomized
盲法
None

入排标准

年龄范围
20.00 Year(s) 至 60.00 Year(s)(—)
性别
All

入选标准

  • Diagnosed cases of bleeding Internal hemorrhoids.(2nd and 3rd Degree) Age 20–60 years of either sex Patients with Hb more than 10mg/dl in male and more than 8mg/dl in females Patients willing to consent and comply Fit for local Dhoopana procedure.

排除标准

  • Non-bleeding or thrombosed haemorrhoids.
  • Other associated conditions like Fistula, fissure, carcinoma Severe anaemia Pregnant/lactating women.
  • Malignancies or bleeding due to systemic causes Chronic bleeding disorders.
  • Uncontrolled diabetes or hypertension Known allergy to ingredients (Rala or Sarshapa Taila) Known patients with Asthma or COPD.

研究者

发起方
Dr Swarnima Nilesh Kucheriya
申办方类型
Other [self]
责任方
Principal Investigator
主要研究者

Dr Swarnima Nilesh Kucheriya

DR G D POL FOUNDATION, YMT Ayurvedic Medical College And Hospital

研究点 (1)

Loading locations...

相似试验